The Cooper Companies Inc. (COO)
Mexican Exchange · Mexico · prices in MXN · close of 15 Oct 2026
Key indicators
| Last close | MXN 985.00 |
|---|---|
| 52-week range | 915.00 – 1,514.40 |
| Return, 1 month / 3 months | +7.7% / −20.8% |
| Return, 1 year / 3 years | −23.3% / −38.8% |
| Trend | Below its 200-day average |
| RSI (14) | 37 |
| Volatility (1 year) | 31.3% |
| Worst drawdown (1 year) | -39.6% |
| Average daily value traded | 0.00M MXN |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
The Cooper Companies is a medical device company based in the United States. Through CooperVision, it makes contact lenses for vision correction, serving eye care professionals and their patients. Through CooperSurgical, it provides medical devices and instruments used in women's health care and fertility treatment. The company supplies these products to hospitals, clinics and eye care practices in many countries around the world.
The Cooper Companies Inc. trades under the code COO on the Mexican Exchange in Mexico, with its price quoted in Mexican pesos (MXN). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
The Cooper Companies Inc. (COO) trades on the Mexican Exchange in Mexico. It last closed at MXN 985.00 on 15 October 2026.
Its price-based Market X-Ray is 15 out of 100 (a weak price profile), ranking 352 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 23.3% and over the last three months it fell 20.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Mexican Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 10 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -19.4% | ||
| From 52-week high | -35.0% | ||
| Momentum | 7 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -20.8% | ||
| 6-month return | -20.7% | ||
| 12-month return, skipping the last month | -28.8% | ||
| Stability (higher is calmer) | 33 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -39.6% | ||
| Liquidity | 8 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M MXN | ||
| Zero-volume days | 88.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +7.7% |
| 3 months | −20.8% |
| 6 months | −20.7% |
| 1 year | −23.3% |
| 3 years | −38.8% |
| 5 years | −49.5% |
Signals
| 50-day / 200-day average | 1,097.83 / 1,222.49 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 6.44 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Jul 2019 | MXN 0.1200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Mexican Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.